Basil A. Molony

4.8k total citations · 1 hit paper
10 papers, 994 citations indexed

About

Basil A. Molony is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Basil A. Molony has authored 10 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pharmacology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Basil A. Molony's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Diabetes Treatment and Management (2 papers). Basil A. Molony is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Diabetes Treatment and Management (2 papers). Basil A. Molony collaborates with scholars based in United States, Australia and United Kingdom. Basil A. Molony's co-authors include Sharon M. Anderson, J. Donald Easton, Barbara Kamm, William K. Hass, Harold P. Adams, William Pryse‐Phillips, Robert R. Gorman, Edward E. Nishizawa, Philip Teitelbaum and Jaymin Shah and has published in prestigious journals such as New England Journal of Medicine, Circulation and Thrombosis and Haemostasis.

In The Last Decade

Basil A. Molony

9 papers receiving 898 citations

Hit Papers

A Randomized Trial Comparing Ticlopidine Hydrochloride wi... 1989 2026 2001 2013 1989 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Basil A. Molony United States 6 609 344 299 242 221 10 994
E Panak France 10 702 1.2× 330 1.0× 277 0.9× 247 1.0× 317 1.4× 14 1.1k
J. A. Blakely Canada 7 509 0.8× 324 0.9× 255 0.9× 207 0.9× 193 0.9× 9 804
Fúster United States 19 1.0k 1.7× 204 0.6× 207 0.7× 171 0.7× 445 2.0× 55 1.6k
J. Zahavi United Kingdom 19 471 0.8× 121 0.4× 214 0.7× 296 1.2× 333 1.5× 37 1.1k
Christine S. Zuern Germany 22 1.4k 2.3× 433 1.3× 162 0.5× 171 0.7× 467 2.1× 75 1.7k
Steen Dalby Kristensen Denmark 22 1.0k 1.7× 131 0.4× 141 0.5× 396 1.6× 279 1.3× 63 1.6k
A Strano Italy 16 627 1.0× 140 0.4× 246 0.8× 111 0.5× 414 1.9× 87 1.3k
Rafał Niżankowski Poland 19 431 0.7× 93 0.3× 221 0.7× 135 0.6× 437 2.0× 68 1.3k
Hans Denison Sweden 19 713 1.2× 582 1.7× 386 1.3× 274 1.1× 743 3.4× 52 1.8k
Mette Hurlen Norway 11 900 1.5× 102 0.3× 72 0.2× 400 1.7× 211 1.0× 18 1.1k

Countries citing papers authored by Basil A. Molony

Since Specialization
Citations

This map shows the geographic impact of Basil A. Molony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basil A. Molony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basil A. Molony more than expected).

Fields of papers citing papers by Basil A. Molony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Basil A. Molony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basil A. Molony. The network helps show where Basil A. Molony may publish in the future.

Co-authorship network of co-authors of Basil A. Molony

This figure shows the co-authorship network connecting the top 25 collaborators of Basil A. Molony. A scholar is included among the top collaborators of Basil A. Molony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Basil A. Molony. Basil A. Molony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Waldron, Dympna, Kirk J. Levins, David Murphy, et al.. (2025). Reflecting on Cancer Pain as Constant Acute Pain, not Chronic Pain. ‘Known Knowns, Known Unknowns, Unknown Unknowns’. Current Oncology Reports. 27(5). 584–600.
2.
Malcolm, Paul N., Jeffrey J. Brown, Peter F. Hahn, et al.. (2000). The clinical value of ferric ammonium citrate: A positive oral contrast agent for T1-weighted MR imaging of the upper abdomen. Journal of Magnetic Resonance Imaging. 12(5). 702–707. 10 indexed citations
3.
Ellis, David, et al.. (1994). In VitroDissolution VersusIn VivoEvaluation of Four Different Aspirin Products. Drug Development and Industrial Pharmacy. 20(10). 1711–1723. 6 indexed citations
4.
Shah, Jaymin, et al.. (1991). Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.. British Journal of Clinical Pharmacology. 32(6). 761–764. 30 indexed citations
5.
Hass, William K., J. Donald Easton, Harold P. Adams, et al.. (1989). A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients. New England Journal of Medicine. 321(8). 501–507. 832 indexed citations breakdown →
6.
Kamm, Barbara, et al.. (1984). Ticlopidine aspirin stroke study. Controlled Clinical Trials. 5(3). 298–298. 2 indexed citations
7.
Bruno, John & Basil A. Molony. (1983). Ticlopidine. Cardiovascular Drug Reviews. 1(1). 295–316. 2 indexed citations
8.
Nishizawa, Edward E., et al.. (1981). Sex-Associated Differences On The Effect Of Asa Or Flurbiprofen On Platelet Function Ex Vivo. Thrombosis and Haemostasis. 1 indexed citations
10.
Nishizawa, Edward E., et al.. (1973). Flurbiprofen, a new potent inhibitor of platelet aggregation. Thrombosis Research. 3(5). 577–588. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026